190 related articles for article (PubMed ID: 38202650)
21. Synthesis, in silico molecular docking analysis, pharmacokinetic properties and evaluation of antibacterial and antioxidant activities of fluoroquinolines.
Fekadu M; Zeleke D; Abdi B; Guttula A; Eswaramoorthy R; Melaku Y
BMC Chem; 2022 Jan; 16(1):1. PubMed ID: 35027086
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs.
Melaku Y; Solomon M; Eswaramoorthy R; Beifuss U; Ondrus V; Mekonnen Y
BMC Chem; 2022 May; 16(1):36. PubMed ID: 35610713
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
Toan DN; Thanh ND; Truong MX; Van DT
Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
[TBL] [Abstract][Full Text] [Related]
24. Green Synthesis of Oxoquinoline-1(2H)-Carboxamide as Antiproliferative and Antioxidant Agents: An Experimental and In-Silico Approach to High Altitude Related Disorders.
Ali A; Ali A; Warsi MH; Rahman MA; Ahsan MJ; Azam F
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011539
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Anti-Cancer Activity of New Pyrazolinyl-Indole Derivatives: Pharmacophoric Interactions and Docking Studies for Identifying New EGFR Inhibitors.
Khalilullah H; Agarwal DK; Ahsan MJ; Jadav SS; Mohammed HA; Khan MA; Mohammed SAA; Khan R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742992
[TBL] [Abstract][Full Text] [Related]
28. Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.
Pavić K; Perković I; Cindrić M; Pranjić M; Martin-Kleiner I; Kralj M; Schols D; Hadjipavlou-Litina D; Katsori AM; Zorc B
Eur J Med Chem; 2014 Oct; 86():502-14. PubMed ID: 25203780
[TBL] [Abstract][Full Text] [Related]
29. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions.
Saini N; Grewal AS; Lather V; Gahlawat SK
Chem Biol Interact; 2022 May; 358():109901. PubMed ID: 35341731
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues.
Ahsan MJ; Choudhary K; Ali A; Ali A; Azam F; Almalki AH; Santali EY; Bakht MA; Tahir A; Salahuddin
Plants (Basel); 2022 Oct; 11(21):. PubMed ID: 36365289
[TBL] [Abstract][Full Text] [Related]
31. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors.
Ewes WA; Elmorsy MA; El-Messery SM; Nasr MNA
Bioorg Med Chem; 2020 Apr; 28(7):115373. PubMed ID: 32085964
[TBL] [Abstract][Full Text] [Related]
33. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
34. Hydrazinecarbonyl-thiazol-2-acetamides with pronounced apoptotic behavior: synthesis, in vitro/in vivo anti-proliferative activity and molecular modeling simulations.
Elsayed RW; Bayoumi SM; El-Subbagh HI; El-Sayed SM
Bioorg Med Chem Lett; 2023 May; 87():129285. PubMed ID: 37054758
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
36. A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-
Ismail MA; Abusaif MS; El-Gaby MSA; Ammar YA; Ragab A
RSC Adv; 2023 Apr; 13(18):12589-12608. PubMed ID: 37101951
[TBL] [Abstract][Full Text] [Related]
37. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
38. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
[TBL] [Abstract][Full Text] [Related]
39. Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties.
Sayed EM; Bakhite EA; Hassanien R; Farhan N; Aly HF; Morsy SG; Hassan NA
BMC Chem; 2024 Feb; 18(1):34. PubMed ID: 38365746
[TBL] [Abstract][Full Text] [Related]
40. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
